RESUMEN
AIM: The position of the body during surgery may affect the patient's body functions, especially the hemodynamic parameters. We aimed to comparatively analyze the effects of lithotomy and prone position on respiratory mechanics, arterial oxygenation, and hemodynamic parameters in patients who underwent percutaneous nephrolithotomy (PNL).
Asunto(s)
Nefrolitotomía Percutánea , Humanos , Posición Prona , Anestesia General , Mecánica Respiratoria , HemodinámicaRESUMEN
Robotic-assisted magnetic resonance imaging (MRI)/transrectal ultrasound (TRUS) fusion transperineal biopsy systems are one of the most debated and interesting subjects both in practice and in current urology literature. The comprehensive literature research was carried out in the PubMed/MEDLINE, Google Scholar, and Scopus databases using the terms "robotic transperineal prostate biopsy," "robot-assisted MRI/US fusion biopsy," "robot-assisted MRI/TRUS fusion biopsy," or "robotic targeted prostate biopsies." All article types were included in the study (n=343). Among these, articles in non-English languages, duplicate articles, review articles, guidelines, and book chapters were excluded from the study (n=325). Additionally, articles on In-bore biopsy and semirigid device techniques were also excluded from the study (n=5). A total of 13 original research studies (3 retrospective and 10 prospective nonrandomized studies; total number of patients=1844) performed with 2 diferent robotic-assisted transperineal biopsy platforms (iSR'obot™ MonaLisa, Biobot Surgical, Singapore; and Artemis™, Eigen,GRASS VALLEY, USA) were analyzed in detail. The overall cancer detection rates ranged from 51.2% to 73.7%, while the rates of detecting clinically significant (cs) prostate cancer (Pca) ranged from 23.0% to 52.7% in patients who had not been previously diagnosed with prostate cancer. Among the 1844 patients, only 2 individuals (0.01%) were diagnosed with urosepsis. Although the role of these devices in prostate biopsies is not completely clear, the robot-assisted transperineal prostate biopsy technique is an efective and safe procedure, with high rates of csPCa detection and acceptable rates of complications, especially in terms of urosepsis.
RESUMEN
Purpose: To investigate the effects of combined tadalafil and testosterone usage on oxidative stress, DNA damage and MMPs in testosterone deficiency.Methods: Fifty rats were randomly divided into 5 groups (group-1: sham group-placebo, group-2: bilateral orchiectomy (ORX), group-3: bilateral ORX+tadalafil, group-4: bilateral ORX+testosterone, group-5: bilateral ORX+tadalafil+testosterone). Group-3 received tadalafil (5mg/kg/day, oral). Group-4 was administered testosterone undecanoate (100mg/kg i.m., single dose). Group-5 was administered a combination of tadalafil and testosterone undecanoate. All groups were compared with regard to serum nicotinamide adenine dinucleotide phosphate oxidase-4 (NOX-4), total thiol, matrix metalloproteinase-2 (MMP-2), MMP-3 and MMP-9, tissue inhibitor of metalloproteinases-1 (TIMP-1) and TIMP-2 and 8-hydroxy-2-deoxy guanosine (8-OHdG) levels.Results: Total thiol levels of group-2 were significantly lower than the other groups and thiol levels were higher in group-1 and group-5 than in the other groups. NOX4, MMP2 and 9 levels in group-2 were higher than in the other groups. MMP-9 levels in group-5 were lower than in groups 3 and 4 (p=.001). The level of 8-OHdG in groups 2 and 3 was higher than in the other groups (p=.001). In correlation analysis, 8-OHdG, MMP2, and 9 levels were negatively correlated with total thiol, whereas NOX4 and 8-OHdG levels were positively correlated with MMPs values.Conclusions: The combination of testosterone with PDE-5 inhibitor suppresses MMP-9 levels and increases total thiol levels better than testosterone alone and tadalafil alone. Therefore, testosterone can be considered for use with PDE-5 inhibitor from the initial stage in case of testosterone deficiency. (AU)
Objetivo: Investigar los efectos del uso combinado de tadalafil y testosterona en cuanto a estrés oxidativo, daño del ADN y metaloproteinasas de la matriz (MMPs) en la deficiencia de testosterona.Métodos: Se dividió aleatoriamente a cincuenta ratas en cinco grupos (grupo-1: grupo de simulación-placebo, grupo-2: orquiectomía bilateral (ORX), grupo-3: ORX bilateral+tadalafil, grupo-4: ORX bilateral+testosterona, grupo-5: ORX bilateral+tadalafil+testosterona). El grupo 3 recibió tadalafil (5mg/kg/day, oral). El Grupo 4 recibió undecanoato de testosterona (100mg/kg i.m, dosis única). El Grupo 5 recibió una combinación de tadalafil y undecanoato de testosterona. Se comparó a todos los grupos con respecto a los niveles séricos de nicotinamida adenina dinucleótido fosfato oxidasa-4 (NOX-4), tiol total, metaloproteinasa de la matriz 2 (MMP-2), MMP-3 y MMP-9, inhibidor tisular de metaloproteinasas-1 (TIMP-1) y TIMP-2, y 8-hidroxi-2-deoxi guanosina (8-OHdG).Resultados: Los niveles totales de tiol del grupo 2 fueron significativamente menores que en el resto de grupos, y los niveles de tiol fueron mayores del grupo 1 y el grupo 5 con respecto a los demás grupos. Los niveles de NOX4, MMP2 y 9 en el grupo 2 fueron mayores que los del resto de grupos. Los niveles de MMP-9 del grupo 5 fueron menores que los de los grupos 3 y 4 (p=0,001). El nivel de 8-OHdG de los grupos 2 y 3 fue mayor que los del resto de grupos (p=0,001). En el análisis de correlación, los niveles de 8-OHdG, MMP2, y 9 guardaron una correlación negativa con tiol total, mientras que los niveles de NOX4 y 8-OHdG se correlacionaron positivamente con los valores de MMPs.Conclusiones: La combinación de testosteronay el inhibidor de PDE-5 suprime los niveles de MMP-9 e incrementa los niveles totales de tiol, de mejor manera que testosterona y tadalafilen solitario. Por tanto, puede considerarse el uso de testosterona con el inhibidor de PDE-5 en las etapas iniciales de deficiencia de testosterona. (AU)
Asunto(s)
Animales , Ratas , Testosterona/uso terapéutico , Inhibidores de Fosfodiesterasa/uso terapéutico , 28573 , Estrés Oxidativo , Metaloproteinasas de la Matriz , Daño del ADNRESUMEN
Objetive: To investigate the diagnosticvalue of testicular fatty acid-binding protein (T-FABP) inacute testicular ischemia and prolonged ischemia.Methods: The study included a total of 28 prepubertal male Wistar-Hannover rats. The animals were randomly divided into 4 groups as torsion groups (group I;min 30; 7 rats, group II; min 120; 7 rats, group III; min240; 7 rats) and control group (group IV; 7 rats). In eachgroup, the left testis was separated from the gubernaculum by blunt dissection together with the tunica vaginalisand spermatic cord, and then exposed. In the controlgroup, the blood samples and left testicular tissues were collected at min 240 after extraction. In torsion groups,the left testis was rotated together with its cord elements,720° in a clockwise direction for the induction of an extravaginal TT model. The blood samples were obtainedat min 30, 120, and 240 in the torsion groups. Bilateraltesticular tissues were collected via orchiectomy for histopathological examination in all groups.Results: The mean plasma T-FABP level in group III (torsion, min 240) was significantly higher than those ofother groups. The T-FABP level at min 240 had a sensitivity and specificity of 100% and 85%, respectively, ata cut-off value of 1.059. A significant difference wasfound between the torsion groups and the control groupwith regard to histopathological scores.Conclusions: The increased T-FABP levels in testicular ischemia seem to be correlated with testicular necrosis rather than acute ischemia.(AU)
Objetivo: Investigar el valor diagnosticode la proteína testicular acido graso (PTAG) en la isquemia testicular aguda y prolongada.Métodos: El estudio involucro 28 ratas Wastar-Hannover varones prepuberales. Los animales fueron randomizados y divididos en 4 grupos: grupo torsión (grupoI; min 30; 7 ratas, grupo II; min 120; 7 ratas, grupoIII; min 240; 7 ratas), grupo control (grupo IV; 7 ratas).En cada grupo, el testículo izquierdo fue separado delgubernáculo con disección, junto con la túnica vaginalisy el cordón espermático, y después fueron expuestos.En el grupo control, la extracción de sangre y tejidotesticular izquierdo fueron recolectados a los 240 minutos de la extracción. En el grupo de torsión, el testículoizquierdo se rotó junto con los elementos del cordónespermático, 720 grados en la dirección de las agujasdel reloj para la inducción de un modelo TT extravaginal. Las muestras de sangre fueron obtenidas a los30 minutos, 120 y 240 minutos en los grupos torsión.Tejido testicular bilateral fue recogido vía orquiectomiapara examen anatomopatológico en todos los grupos.Resultados: El nivel medio de PTAG en el grupo III(torsión 240 min) fue significativamente superior a losdemás grupos. El nivel de PTAG a los 240 minutos tuvouna sensibilidad y especificidad del 100% y 85%, respectivamente a un valor de corte de 1.059. Se encontróuna diferencia significativa entre los grupos de torsión ycontrol en relación a los scores anatomopatológicos.Conclusiones: Los niveles elevados de PTAG enla isquemia testicular parecen correlacionados con lanecrosis testicular más que con la isquemia aguda.(AU)
Asunto(s)
Humanos , Animales , Ácidos Grasos , Isquemia , Necrosis , Torsión del Cordón Espermático , Proteínas , Testículo , Testículo/anomalíasRESUMEN
ABSTRACT Purpose We aimed to compare the outcomes of supine and prone miniaturized percutaneous nephrolithotomy (m-PNL) in the treatment of lower pole, middle pole and renal pelvic stones. Materials and Methods 54 patients who performed supine m-PNL between January 2017 and March 2018 and 498 patients who performed prone m-PNL between April 2015 and January 2018 were included in the study. Of the 498 patients, 108 matching 1: 2 in terms of age, gender, body mass index, American Association of Anesthesiology score, stone size, stone localization and hydronephrosis according to the supine m-PNL group were selected as prone m-PNL group. The patients with solitary kidney, upper pole stone, urinary system anomaly or skeletal malformation and pediatric patients (<18 years old) were excluded from the study. The success was defined as 'complete stone clearance' and was determined according to the 1st month computed tomography. Results The operation time and fluoroscopy time in supine m-PNL was significantly shorter than prone m-PNL group (58.1±45.9 vs. 80.1±40.0 min and 3.0±1.7 min vs. 4.9±4.5 min, p=0.025 and p=0.01, respectively). When post-operative complications were compared according to the modified Clavien-Dindo classification, overall and subgroup complication rates were comparable between groups. There was no significant difference between the groups in terms of the success rates (supine m-PNL; 72.2%, prone m-PNL; 71.3%, p=0.902). Conclusions Supine m-PNL procedure is more advantageous in terms of operation time and fluoroscopy time in the treatment of lower pole, middle pole and renal pelvic stones.
Asunto(s)
Humanos , Masculino , Femenino , Adulto , Cálculos Renales/cirugía , Posición Supina , Posición Prona , Posicionamiento del Paciente/métodos , Nefrolitotomía Percutánea/métodos , Fluoroscopía/métodos , Cálculos Renales/patología , Reproducibilidad de los Resultados , Resultado del Tratamiento , Análisis por Apareamiento , Estadísticas no Paramétricas , Tempo Operativo , Pelvis Renal/cirugía , Persona de Mediana EdadRESUMEN
ABSTRACT Introduction: Durasphere® EXP (DEXP) is a compound of biocompatible and non--biodegradable particles of zirconium oxide covered with pyrolytic carbon. The aim of this study is to evaluate the durability of off-label use of DEXP in the treatment of primary vesicoureteral reflux in children. Materials and Methods: Patients who underwent subureteric injection of DEXP for the correction of primary VUR were retrospectively reviewed. Patients aged >18 years as well as those who had grade-I or -V VUR, anatomic abnormalities (duplicated system, hutch diverticulum), neurogenic bladder or treatment refractory voiding dysfunction were excluded. Radiologic success was defined as the resolution of VUR at the 3rd month control. Success was radiographically evaluated at the end of the first year. Results: Thirty-eight patients (9 boys, 29 girls; mean age, 6.3±2.7 years) formed the study cohort. Forty-six renal units received DEXP (grade II: 22; grade III: 18; grade IV: 6). Mean volume per ureteric orifice to obtain the mound was 0.70±0.16mL. First con- trol VCUG was done after 3 months in all patients. After the first VCUG, 6 patients had VUR recurrence. Short-term radiologic success of DEXP was 84.2%. Rate of radiologic success at the end of the first year was 69.4% (25/32). Lower age (p:0.006) and lower amount of injected material (p:0.05) were associated with higher success rates at the end of 1 year. Conclusion: This is the first study to assess the outcomes of DEXP for treatment of primary VUR in children. After 1 year of follow-up, DEXP had a 69.4% success rate.
Asunto(s)
Humanos , Masculino , Femenino , Preescolar , Niño , Reflujo Vesicoureteral/tratamiento farmacológico , Circonio/uso terapéutico , Materiales Biocompatibles/uso terapéutico , Glucanos/uso terapéutico , Recurrencia , Reflujo Vesicoureteral/cirugía , Índice de Severidad de la Enfermedad , Reproducibilidad de los Resultados , Estudios Retrospectivos , Dextranos/uso terapéutico , Resultado del Tratamiento , Estadísticas no Paramétricas , Endoscopía/métodos , Ácido Hialurónico/uso terapéutico , InyeccionesRESUMEN
ABSTRACT Purpose Premature ejaculation is considered the most common type of male sexual dysfunction. Hormonal controls of ejaculation have not been exactly elucidated. The aim of our study is to investigate the role of hormonal factors in patients with premature ejaculation. Materials and Methods Sixty-three participants who consulted our outpatient clinics with complaints of premature ejaculation and 39 healthy men as a control group selected from volunteers were included in the study. A total of 102 sexual active men aged between 21 and 76 years were included. Premature ejaculation diagnostic tool questionnaires were used to assessment of premature ejaculation. Serum levels of follicle stimulating hormone, luteinizing hormone, prolactin, total and free testosterone, thyroid-stimulating hormone, free triiodothyronine and thyroxine were measured. Results Thyroid-stimulating hormone, luteinizing hormone, and prolactin levels were significantly lower in men with premature ejaculation according to premature ejaculation diagnostic tool (p=0.017, 0.007 and 0.007, respectively). Luteinizing hormone level (OR, 1.293; p=0.014) was found to be an independent risk factor for premature ejaculation. Conclusions Luteinizing hormone, prolactin, and thyroid-stimulating hormone levels are associated with premature ejaculation which was diagnosed by premature ejaculation diagnostic tool questionnaires. The relationship between these findings have to be determined by more extensive studies.